Expertise in
8
conditions

Dr. Ramesh Rengan

Radiation Oncology
Gme Office University Of Washington
1959 NE Pacific St, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Expertise in
8
conditions
Gme Office University Of Washington
1959 NE Pacific St, 
Seattle, WA 

Overview

Ramesh Rengan is a Radiation Oncologist practicing medicine in Seattle, Washington.

Dr. Rengan is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Melanoma of the Eye, and Prostate Cancer.

He is actively involved in clinical research, co-authoring 108 peer reviewed articles and participating in 5 clinical trials. Dr. Rengan is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in WA

Languages Spoken

English
Mandarin
Tamil

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO

Locations

Gme Office University of Washington
1959 NE Pacific St, Seattle, WA 98195
Other Locations
Seattle Proton Center LLC
1570 N 115th St, Seattle, WA 98133

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2026
Intervention Type: Other, Drug, Biological, Radiation
Study Drugs: Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium
Study Phase: Phase 3
Personalized Radiation Therapy Through Functional Lung Avoidance and Response-Adaptive Dose Escalation: Utilizing Multimodal Molecular Imaging to Improve the Therapeutic Ratio (FLARE RT)
Personalized Radiation Therapy Through Functional Lung Avoidance and Response-Adaptive Dose Escalation: Utilizing Multimodal Molecular Imaging to Improve the Therapeutic Ratio (FLARE RT)
Enrollment Status: Completed
Publish Date: August 14, 2024
Intervention Type: Procedure, Radiation, Other
Study Phase: Phase 2
Adaptive-Dose to Mediastinum With Immunotherapy (Durvalumab MEDI4736) and Radiation in Locally-Advanced Non-Small Cell Lung Cancer
Adaptive-Dose to Mediastinum With Immunotherapy (Durvalumab MEDI4736) and Radiation in Locally-Advanced Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: June 13, 2023
Intervention Type: Drug, Biological, Radiation
Study Drugs: Cisplatin, Durvalumab, Etoposide, Pemetrexed
Study Phase: Phase 2
ImmunoRad: Stratified Phase II Trial of Image Guided Hypofractionated Radiotherapy With Concurrent Nelfinavir and Immunotherapy in Advanced Melanoma, Lung Cancer, and Renal Cell Carcinoma
ImmunoRad: Stratified Phase II Trial of Image Guided Hypofractionated Radiotherapy With Concurrent Nelfinavir and Immunotherapy in Advanced Melanoma, Lung Cancer, and Renal Cell Carcinoma
Enrollment Status: Terminated
Publish Date: June 22, 2022
Intervention Type: Biological, Other, Drug, Radiation
Study Drugs: Atezolizumab, Nelfinavir Mesylate, Nivolumab, Pembrolizumab
Study Phase: Phase 2
RADVAX: A Stratified Phase II Dose Escalation Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Metastatic Melanoma
RADVAX: A Stratified Phase II Dose Escalation Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Metastatic Melanoma
Enrollment Status: Terminated
Publish Date: February 13, 2020
Intervention Type: Biological, Other, Radiation
Study Phase: Phase 2
View 4 Less Clinical Trials

108 Total Publications

Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC.
Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 18, 2025
Similar Doctors
Expertise in
21
conditions
Dr. Simon S. Lo
Radiation Oncology
Expertise in
21
conditions
Dr. Simon S. Lo
Radiation Oncology
Referral may be required

Gme Office University Of Washington

1959 NE Pacific St, 
Seattle, WA 
 (0.1 miles away)
206-598-4100
Languages Spoken:
English, Cantonese, Hindi, Kannada, Mandarin, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Simon Lo is a Radiation Oncologist practicing medicine in Seattle, Washington. Dr. Lo is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioma, Astrocytoma, Pancreaticoduodenectomy, and Endoscopy. Dr. Lo is currently accepting new patients.

Expertise in
28
conditions
Dr. Lia M. Halasz
Radiation Oncology
Expertise in
28
conditions
Dr. Lia M. Halasz
Radiation Oncology
Referral may be required

Summit Cardiology Trust

1560 N 115th St, 
Seattle, WA 
 (4.6 miles away)
Languages Spoken:
English, German, Korean, Portuguese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Lia Halasz is a Radiation Oncologist practicing medicine in Seattle, Washington. Dr. Halasz is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Oligodendroglioma, Astrocytoma, Brain Tumor, and Glioblastoma. Dr. Halasz is currently accepting new patients.

Expertise in
18
conditions
Dr. Yolanda D. Tseng
Radiation Oncology
Expertise in
18
conditions
Dr. Yolanda D. Tseng
Radiation Oncology
Referral may be required

Seattle Proton Center LLC

1570 N 115th St, 
Seattle, WA 
 (4.6 miles away)
206-306-2800
Experience:
17+ years
Languages Spoken:
English, Filipino, French, Mandarin, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Yolanda Tseng is a Radiation Oncologist practicing medicine in Seattle, Washington. She has been practicing medicine for over 17 years. Dr. Tseng is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, and Ependymoma. Dr. Tseng is currently accepting new patients.

Frequently Asked Questions about Dr. Ramesh Rengan

How do I make an appointment with Dr. Ramesh Rengan?

You can book an appointment with Dr. Ramesh Rengan by calling their office at 206-598-4100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ramesh Rengan a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ramesh Rengan is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ramesh Rengan specialize in?

While Dr. Ramesh Rengan is a Radiation Oncology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Melanoma of the Eye. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Ramesh Rengan participate in research or clinical trials?

Yes. Dr. Ramesh Rengan has published 108 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Ramesh Rengan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ramesh Rengan accept my insurance?

Dr. Ramesh Rengan accepts most major insurance plans, including Humana and PacificSource. We recommend calling the office directly at 206-598-4100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rengan's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile